← Back to headlines
FDA Reverses Course on Moderna's Flu Shot Review
The FDA has reversed its previous decision and will now review Moderna's flu shot, potentially paving the way for its approval and market entry.
18 Feb, 19:59 — 18 Feb, 19:59
The FDA has reversed its previous decision and will now review Moderna's flu shot, potentially paving the way for its approval and market entry.
18 Feb, 19:59 — 18 Feb, 19:59
